AGIOS PHARMACEUTICALS, INC. Increase (Decrease) in Inventories
AGIOS PHARMACEUTICALS, INC. (AGIO) reported Increase (Decrease) in Inventories of -$2.77 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-07-30
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in inventories for the quarter ending 2026-06-30 was -$4.93M, a 497.02% decline year-over-year.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in inventories for the quarter ending 2026-03-31 was $2.17M, a 8.95% increase year-over-year.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in inventories for the quarter ending 2025-12-31 was $886.00K, a 25.36% decline year-over-year.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in inventories for the quarter ending 2025-09-30 was $1.19M, a 52.41% decline year-over-year.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in inventories for fiscal 2025 was $5.30M, a 37.89% decline from fiscal 2024.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in inventories for fiscal 2024 was $8.54M, a 19.31% decline from fiscal 2023.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in inventories for fiscal 2023 was $10.58M, a 24.63% increase from fiscal 2022.
- AGIOS PHARMACEUTICALS, INC. increase (decrease) in inventories for fiscal 2022 was $8.49M.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month | Increase (Decrease) in Inventories 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | -$4.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | -$2.77M 10-Q · filed 2026-07-30 | -$1.88M derived: sum of 3 quarters · filed 2026-07-30 | -$696.00K derived: sum of 4 quarters · filed 2026-07-30 | |
| 2026-03-31 | $2.17M 10-Q · filed 2026-04-29 | $3.05M derived: sum of 2 quarters · filed 2026-04-29 | $4.24M derived: sum of 3 quarters · filed 2026-04-29 | $5.48M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-12-31 | $886.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $2.07M derived: sum of 2 quarters · filed 2026-02-12 | $3.31M derived: sum of 3 quarters · filed 2026-07-30 | $5.30M 10-K · filed 2026-02-12 | |
| 2025-09-30 | $1.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $2.43M derived: sum of 2 quarters · filed 2026-07-30 | $4.42M 10-Q · filed 2025-10-30 | $5.61M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-06-30 | $1.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $3.23M 10-Q · filed 2026-07-30 | $4.42M derived: sum of 3 quarters · filed 2026-07-30 | $6.91M derived: sum of 4 quarters · filed 2026-07-30 | |
| 2025-03-31 | $1.99M 10-Q · filed 2026-04-29 | $3.18M derived: sum of 2 quarters · filed 2026-04-29 | $5.67M derived: sum of 3 quarters · filed 2026-04-29 | $6.54M derived: sum of 4 quarters · filed 2026-04-29 | |
| 2024-12-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $3.68M derived: sum of 2 quarters · filed 2026-02-12 | $4.55M derived: sum of 3 quarters · filed 2026-02-12 | $8.54M 10-K · filed 2026-02-12 | |
| 2024-09-30 | $2.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $3.36M derived: sum of 2 quarters · filed 2025-10-30 | $7.35M 10-Q · filed 2025-10-30 | $9.15M derived: sum of 4 quarters · filed 2026-02-12 | |
| 2024-06-30 | $867.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $4.86M 10-Q · filed 2025-07-31 | $6.66M derived: sum of 3 quarters · filed 2026-02-12 | $8.27M derived: sum of 4 quarters · filed 2026-02-12 | |
| 2024-03-31 | $3.99M 10-Q · filed 2025-05-01 | $5.80M derived: sum of 2 quarters · filed 2026-02-12 | $7.40M derived: sum of 3 quarters · filed 2026-02-12 | $11.70M derived: sum of 4 quarters · filed 2026-02-12 | |
| 2023-12-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12 | $3.40M derived: sum of 2 quarters · filed 2026-02-12 | $7.70M derived: sum of 3 quarters · filed 2026-02-12 | $10.58M 10-K · filed 2026-02-12 | |
| 2023-09-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $5.90M derived: sum of 2 quarters · filed 2024-10-31 | $8.78M 10-Q · filed 2024-10-31 | $12.10M derived: sum of 4 quarters · filed 2025-02-13 | |
| 2023-06-30 | $4.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $7.18M 10-Q · filed 2024-08-01 | $10.49M derived: sum of 3 quarters · filed 2025-02-13 | $11.61M derived: sum of 4 quarters · filed 2025-02-13 | |
| 2023-03-31 | $2.88M 10-Q · filed 2024-05-02 | $6.20M derived: sum of 2 quarters · filed 2025-02-13 | $7.31M derived: sum of 3 quarters · filed 2025-02-13 | $8.89M derived: sum of 4 quarters · filed 2025-02-13 | |
| 2022-12-31 | $3.32M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13 | $4.43M derived: sum of 2 quarters · filed 2025-02-13 | $6.01M derived: sum of 3 quarters · filed 2025-02-13 | $8.49M 10-K · filed 2025-02-13 | |
| 2022-09-30 | $1.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $2.69M derived: sum of 2 quarters · filed 2023-11-02 | $5.18M 10-Q · filed 2023-11-02 | $5.18M derived: sum of 4 quarters · filed 2024-02-15 | |
| 2022-06-30 | $1.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $4.06M 10-Q · filed 2023-08-03 | $4.06M derived: sum of 3 quarters · filed 2024-02-15 | $4.06M derived: sum of 4 quarters · filed 2024-02-15 | |
| 2022-03-31 | $2.48M 10-Q · filed 2023-05-04 | $2.48M derived: sum of 2 quarters · filed 2024-02-15 | $2.48M derived: sum of 3 quarters · filed 2024-02-15 | $2.48M derived: sum of 4 quarters · filed 2024-02-15 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | $0.00 derived: sum of 2 quarters · filed 2024-02-15 | $0.00 derived: sum of 3 quarters · filed 2024-02-15 | $0.00 10-K · filed 2024-02-15 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $0.00 derived: sum of 2 quarters · filed 2022-11-03 | $0.00 10-Q · filed 2022-11-03 | -$4.04M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $0.00 10-Q · filed 2022-08-04 | -$4.04M derived: sum of 3 quarters · filed 2023-02-23 | -$3.90M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-05 | -$4.04M derived: sum of 2 quarters · filed 2023-02-23 | -$3.90M derived: sum of 3 quarters · filed 2023-02-23 | -$2.45M derived: sum of 4 quarters · filed 2023-02-23 | |
| 2020-12-31 | -$4.04M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | -$3.90M derived: sum of 2 quarters · filed 2023-02-23 | -$2.45M derived: sum of 3 quarters · filed 2023-02-23 | $0.00 10-K · filed 2023-02-23 | $7.37M 10-K · filed 2021-02-25 |
| 2020-09-30 | $140.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $1.59M derived: sum of 2 quarters · filed 2020-11-05 | $4.04M 10-Q · filed 2020-11-05 | $5.52M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2020-06-30 | $1.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $3.90M 10-Q · filed 2020-07-30 | $5.38M derived: sum of 3 quarters · filed 2021-02-25 | $6.57M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2020-03-31 | $2.45M 10-Q · filed 2020-04-30 | $3.93M derived: sum of 2 quarters · filed 2021-02-25 | $5.12M derived: sum of 3 quarters · filed 2021-02-25 | $7.45M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-12-31 | $1.48M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $2.67M derived: sum of 2 quarters · filed 2021-02-25 | $5.00M derived: sum of 3 quarters · filed 2021-02-25 | $6.46M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $1.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $3.52M derived: sum of 2 quarters · filed 2020-11-05 | $4.98M 10-Q · filed 2020-11-05 | $4.99M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-06-30 | $2.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $3.79M 10-Q · filed 2020-07-30 | $3.80M derived: sum of 3 quarters · filed 2021-02-25 | $4.66M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2019-03-31 | $1.46M 10-Q · filed 2020-04-30 | $1.47M derived: sum of 2 quarters · filed 2021-02-25 | $2.33M derived: sum of 3 quarters · filed 2021-02-25 | $2.33M derived: sum of 4 quarters · filed 2021-02-25 | |
| 2018-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $869.00K derived: sum of 2 quarters · filed 2021-02-25 | $869.00K derived: sum of 3 quarters · filed 2021-02-25 | $869.00K 10-K · filed 2021-02-25 | |
| 2018-09-30 | $863.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $863.00K derived: sum of 2 quarters · filed 2019-10-31 | $863.00K 10-Q · filed 2019-10-31 | $863.00K derived: sum of 4 quarters · filed 2020-02-19 | |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $0.00 10-Q · filed 2019-08-01 | $0.00 derived: sum of 3 quarters · filed 2020-02-19 | ||
| 2018-03-31 | $0.00 10-Q · filed 2019-05-02 | $0.00 derived: sum of 2 quarters · filed 2020-02-19 | |||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $0.00 10-K · filed 2020-02-19 | |||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-01 | ||||
| 2016-12-31 | $0.00 10-K · filed 2019-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |